{"id":143280,"date":"2026-07-08T12:00:10","date_gmt":"2026-07-08T06:30:10","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=143280"},"modified":"2026-07-08T12:00:20","modified_gmt":"2026-07-08T06:30:20","slug":"marksans-pharma-share-price-abcnow-germany-acquisition","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/marksans-pharma-share-price-abcnow-germany-acquisition\/","title":{"rendered":"Marksans Pharma Share Price Rises 3.24% After Agreeing to Acquire Germany-Based ABCnow GmbH for Euro 0.9 Million"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Marksans Pharma Rs 269.50, up 3.24% on 8 Jul 2026. Agrees to acquire 100% of ABCnow GmbH, Germany, for Euro 0.9 million. Extends European footprint after Netherlands QliniQ deal.<\/em><\/p>\n<p><a href=\"https:\/\/univest.in\/user\/stocks\/marksans\/marksans-pharma-ltd-share-price-today\">Marksans Pharma<\/a> share price rose 3.24 percent to Rs 269.50 on Wednesday, 8 July 2026, after the company entered into a definitive agreement to acquire 100 percent of the share capital of ABCnow GmbH, a Germany based pharmaceutical company, for a consideration of Euro 0.9 million.<\/p>\n<p>ABCnow GmbH brings frontend sales, marketing and distribution capabilities across the German healthcare market, extending Marksans Pharma&#8217;s European footprint beyond its earlier acquisition of Netherlands based QliniQ B.V.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=marksans-pharma-abcnow-germany-deal\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/marksans-pharma-share-price-abcnow-germany-acquisition\/#Marksans_Pharma_Share_Price_Today_Acquisition_Details\" title=\"Marksans Pharma Share Price Today: Acquisition Details\">Marksans Pharma Share Price Today: Acquisition Details<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/marksans-pharma-share-price-abcnow-germany-acquisition\/#Why_the_ABCnow_Acquisition_Matters_for_the_Marksans_Pharma_Share_Price\" title=\"Why the ABCnow Acquisition Matters for the Marksans Pharma Share Price\">Why the ABCnow Acquisition Matters for the Marksans Pharma Share Price<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/marksans-pharma-share-price-abcnow-germany-acquisition\/#What_Should_Investors_Watch_in_the_Marksans_Pharma_Share_Price\" title=\"What Should Investors Watch in the Marksans Pharma Share Price\">What Should Investors Watch in the Marksans Pharma Share Price<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/marksans-pharma-share-price-abcnow-germany-acquisition\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/marksans-pharma-share-price-abcnow-germany-acquisition\/#Frequently_Asked_Questions_FAQs\" title=\"Frequently Asked Questions FAQs\">Frequently Asked Questions FAQs<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/marksans-pharma-share-price-abcnow-germany-acquisition\/#What_acquisition_did_Marksans_Pharma_announce\" title=\"What acquisition did Marksans Pharma announce?\">What acquisition did Marksans Pharma announce?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/marksans-pharma-share-price-abcnow-germany-acquisition\/#What_is_the_Marksans_Pharma_share_price_today\" title=\"What is the Marksans Pharma share price today?\">What is the Marksans Pharma share price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/marksans-pharma-share-price-abcnow-germany-acquisition\/#What_does_ABCnow_GmbH_do\" title=\"What does ABCnow GmbH do?\">What does ABCnow GmbH do?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/marksans-pharma-share-price-abcnow-germany-acquisition\/#Has_Marksans_Pharma_made_similar_European_acquisitions_before\" title=\"Has Marksans Pharma made similar European acquisitions before?\">Has Marksans Pharma made similar European acquisitions before?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/marksans-pharma-share-price-abcnow-germany-acquisition\/#Why_is_trading_volume_relevant_for_Marksans_Pharma_today\" title=\"Why is trading volume relevant for Marksans Pharma today?\">Why is trading volume relevant for Marksans Pharma today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/marksans-pharma-share-price-abcnow-germany-acquisition\/#Should_investors_buy_Marksans_Pharma_shares_after_the_ABCnow_deal\" title=\"Should investors buy Marksans Pharma shares after the ABCnow deal?\">Should investors buy Marksans Pharma shares after the ABCnow deal?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/marksans-pharma-share-price-abcnow-germany-acquisition\/#How_can_investors_track_the_Marksans_Pharma_share_price_live\" title=\"How can investors track the Marksans Pharma share price live?\">How can investors track the Marksans Pharma share price live?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Marksans_Pharma_Share_Price_Today_Acquisition_Details\"><\/span><strong>Marksans Pharma Share Price Today: Acquisition Details<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Metric<\/th>\n<th>Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Stock<\/td>\n<td><a href=\"https:\/\/univest.in\/stocks\/marksans\/marksans-pharma-ltd-share-price-today\">Marksans Pharma<\/a><\/td>\n<\/tr>\n<tr>\n<td>CMP (8 July 2026)<\/td>\n<td>Rs 269.50<\/td>\n<\/tr>\n<tr>\n<td>Day Change<\/td>\n<td>+3.24 percent<\/td>\n<\/tr>\n<tr>\n<td>Target Company<\/td>\n<td>ABCnow GmbH, Germany<\/td>\n<\/tr>\n<tr>\n<td>Stake Acquired<\/td>\n<td>100 percent of share capital<\/td>\n<\/tr>\n<tr>\n<td>Deal Value<\/td>\n<td>Euro 0.9 million<\/td>\n<\/tr>\n<tr>\n<td>Strategic Rationale<\/td>\n<td>Frontend sales, marketing and distribution in Germany<\/td>\n<\/tr>\n<tr>\n<td>Intraday High \/ Low<\/td>\n<td>Rs 269.65 \/ Rs 259.50<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/sebi-registered-investment-advisor-india\"><strong>Get Pharma and Export Stock Guidance from a SEBI Registered Investment Advisor at Univest<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_the_ABCnow_Acquisition_Matters_for_the_Marksans_Pharma_Share_Price\"><\/span><strong>Why the ABCnow Acquisition Matters for the Marksans Pharma Share Price<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The ABCnow deal is a small bolt on acquisition relative to Marksans Pharma&#8217;s scale, but it fits the company&#8217;s stated strategy of building direct market access capabilities across regulated European markets. Germany is one of Europe&#8217;s largest pharmaceutical markets, and owning frontend sales and distribution infrastructure there can help Marksans Pharma commercialise its existing and future product pipeline more directly, rather than relying solely on third party distributors.<\/p>\n<p>This follows Marksans Pharma&#8217;s earlier acquisition of QliniQ B.V. in the Netherlands for Euro 7.5 million, completed in June 2026, indicating a consistent pattern of inorganic expansion into regulated European markets as part of the company&#8217;s broader growth strategy toward its Rs 4,000 crore FY28 revenue target.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Should_Investors_Watch_in_the_Marksans_Pharma_Share_Price\"><\/span><strong>What Should Investors Watch in the Marksans Pharma Share Price<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Investors tracking the Marksans Pharma share price should watch the integration timeline for ABCnow, revenue contribution from the enlarged European operations, and progress on the company&#8217;s broader FY27 growth guidance of 15 to 20 percent revenue growth. Trading volumes today were also notably lower than average, an important context for today&#8217;s price move.<\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track the Marksans Pharma share price live and get more Marksans Pharma share price research.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Marksans Pharma agreed to acquire 100 percent of Germany based ABCnow GmbH for Euro 0.9 million, extending its European footprint after the earlier QliniQ B.V. deal in the Netherlands. The stock rose 3.24 percent to Rs 269.50 on 8 July 2026. Investors should track integration progress and consult a SEBI registered advisor before investing.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_FAQs\"><\/span><strong>Frequently Asked Questions FAQs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_acquisition_did_Marksans_Pharma_announce\"><\/span><strong>What acquisition did Marksans Pharma announce?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Marksans Pharma entered into a definitive agreement to acquire 100 percent of the share capital of ABCnow GmbH, a Germany based pharmaceutical company, for a consideration of Euro 0.9 million.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Marksans_Pharma_share_price_today\"><\/span><strong>What is the Marksans Pharma share price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Marksans Pharma share price was trading at Rs 269.50 on 8 July 2026, up 3.24 percent, with an intraday range of Rs 259.50 to Rs 269.65.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_ABCnow_GmbH_do\"><\/span><strong>What does ABCnow GmbH do?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> ABCnow GmbH is a Germany based pharmaceutical company with frontend sales, marketing and distribution capabilities across the German healthcare market.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Has_Marksans_Pharma_made_similar_European_acquisitions_before\"><\/span><strong>Has Marksans Pharma made similar European acquisitions before?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes, Marksans Pharma completed the acquisition of Netherlands based QliniQ B.V. for Euro 7.5 million in June 2026, and the ABCnow deal extends the same strategy of building direct market access in regulated European markets.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_trading_volume_relevant_for_Marksans_Pharma_today\"><\/span><strong>Why is trading volume relevant for Marksans Pharma today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Marksans Pharma traded with volumes of 88,215 shares on 8 July 2026, compared to its five day average of 127,181 shares, a decrease of 30.64 percent, providing context for the day&#8217;s price move.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Should_investors_buy_Marksans_Pharma_shares_after_the_ABCnow_deal\"><\/span><strong>Should investors buy Marksans Pharma shares after the ABCnow deal?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> A small bolt on acquisition supports long term strategy but is unlikely to move near term financials materially. Investors should track integration progress and overall FY27 growth, and consult a SEBI registered investment advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_can_investors_track_the_Marksans_Pharma_share_price_live\"><\/span><strong>How can investors track the Marksans Pharma share price live?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors can track the Marksans Pharma share price live on the NSE and BSE websites, as well as on broker and research platforms that cover the stock.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Marksans Pharma share price rose 3.24% to Rs 269.50 on 8 July 2026 after the company agreed to acquire 100% of Germany based ABCnow GmbH for a consideration of Euro 0.9 million.<\/p>\n","protected":false},"author":35,"featured_media":143301,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802,3930],"class_list":["post-143280","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news","tag-share-price-rises"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1783492224:28"],"_last_editor_used_jetpack":["block-editor"],"_thumbnail_id":["143301"],"rank_math_primary_category":["842"],"rank_math_seo_score":["75"],"rank_math_title":["Marksans Pharma Share Price: To Acquire German Firm ABCnow"],"rank_math_description":["Marksans Pharma share price rose 3.24% to Rs 269.50 on 8 July 2026 after the company agreed to acquire 100% of Germany based ABCnow GmbH for a consideration of Euro 0.9 million."],"rank_math_focus_keyword":["Marksans Pharma share price"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["24303"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/07\/Marksans-Pharma-Share-Price-Rises.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/143280","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=143280"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/143280\/revisions"}],"predecessor-version":[{"id":143302,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/143280\/revisions\/143302"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/143301"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=143280"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=143280"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=143280"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}